Actinic keratosis modelling in mice: A translational study

Arnaud Pillon1, Bruno Gomes1, Isabelle Vandenberghe1

  • 1Pierre Fabre Research Institute, Research & Development Center, Toulouse, France.

Plos One
|June 30, 2017
PubMed
Abstract

Insights

This study validates a UV-B-induced mouse model for actinic keratosis (AK) and squamous cell carcinoma (SCC) development. The model accurately predicts therapeutic treatments for early and advanced skin lesions.

Area of Science:

  • Dermatology
  • Preclinical Research
  • Cancer Biology

Background:

  • Actinic keratoses (AK) are pre-malignant skin lesions progressing to squamous cell carcinoma (SCC).
  • Current AK treatments require efficacy improvement.
  • UV-B-induced mouse models are used for preclinical AK/SCC studies.

Purpose of the Study:

  • To compare human and UV-B-induced mouse AK lesion development.
  • To optimize photographic assessment of mouse AK lesions.
  • To validate a mouse model for predicting therapeutic efficacy.

Main Methods:

  • Histological and immunohistochemical analysis of human and mouse AK lesions.
  • Assessment of mouse lesions using digital dermoscopy.
  • Optimization of digital dermoscopy for reproducible imaging.

Main Results:

  • Mouse AK models show histological and phenotypic similarities to human lesions.
  • Differences in keratinocyte disorganization and acanthosis were noted.
  • Optimized digital dermoscopy enables reliable assessment and selection of experimental conditions.

Conclusions:

  • The UV-B-induced mouse model is relevant for studying AK and SCC.
  • This model can predict novel therapeutic treatments for early and advanced skin lesions.
  • Optimized imaging enhances the model's utility in preclinical research.